David A. Griffith
Pfizer (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Carbohydrate Chemistry and Synthesis, Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Glycosylation and Glycoproteins Research
Most-Cited Works
- → SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1(2010)890 cited
- → Sulfonamidoglycosylation of glycals. A route to oligosaccharides with 2-aminohexose subunits(1990)219 cited
- → Total synthesis of allosamidin: an application of the sulfonamidoglycosylation of glycals(1991)159 cited
- → A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor(2022)146 cited
- → Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable(2014)139 cited
- → Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial(2021)135 cited
- → Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys